Transforming diabetes management in cardiology: Impact of novel therapies
EBAC-accredited E-LearningOnline-CME - This course consists of 3 lectures.
During this educational program, the effect of GLP-RAs in diabets patients is disscussed in three lectures.
This course consists of the following lectures:
- The diabetes challenge for cardiologists: The key things to understand - Prof. Naveed Sattar, MD - Glasgow, United Kingdom
- Cardiac mechanisms of GLP-1 receptor agonists - Prof. Filip Krag Knop, MD – Copenhagen, Denmark
- The clinical perspectives of targeting GLP-1 RA: Where does it fit into CV risk management? - Prof. John Deanfield, MD - London, United Kingdom
After watching these three videos, the learner should be able to:
- Understand the relation between T2DM & CVD
- Recall results from recent cardiovascular outcome trials (CVOT) in T2DM and be aware of differences between the members within the class
- Discuss potential mechanisms and multifactorial effects of GLP-1 receptor agonists contributing to cardiovascular benefits
- Discuss practical implications from recent CVOTs on treatment and prevention strategies in patients with CV risk and T2DM
- Prof. Naveed Sattar, MD, Professor of Metabolic Medicine, University of Glasgow. He is an academic (active clinically) experienced in biomarker studies/trials investigating the causes, prevention and management of diabetes, obesity and heart disease.
- Prof. Filip Krag Knop, MD, Professor of endocrinology and Director of Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Denmark
- Prof. John Deanfield - Professor of Cardiology at University College London (UCL) and Consultant Cardiologist at the Barts Heart Centre (BHC) London UK. He is the Director of the National Centre for Cardiovascular disease Prevention and Outcomes (NCCPO) at UCL, and Chairman of National Institute for Cardiovascular (CV) Outcomes Research (NICOR)
This educational activity is designed for cardiologists in secondary care and other healthcare professionals with an interest in treating diabetes patients with CVD.
This online course is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credit.
Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.
Funding for this educational program was provided by an unrestricted educational grant from Novo Nordisk A/S.
This is available as accredited online CME for members. Click the button below to enroll:Enroll